// App-Quantinova.ai

2126 : Androgen receptor expression is associated with sunitinib resistance in renal cell carcinoma models

Researchers

Presenter

  • Remi M. Adelaiye-Ogala

Principal Investigators

  • Sreenivasulu Chintala

  • Ashley Orillion

  • Piergiorgio Pettazzoni

  • May Elbanna

  • Bennett Elzey

  • Kiersten Marie Miles

  • Chinghai Kao

  • Giulio F. Draetta

  • Roberto Pili

Medical Centers

  • Indiana University-Purdue University, Indianapolis, IN.

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Purdue University, Lafayette, IN

  • Roswell Park Cancer Institute, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Metastatic Renal Cell Cancer

  • Solid malignancies

  • Clear cell renal carcinoma

Biomarkers

  • Androgen receptor

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Sunitinib

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved